Registry of anti-cancer treatment response prediction tool, CANscript, to understand its use in clinics and impact on the patient treatment outcome.
Not Applicable
- Conditions
- Health Condition 1: null- Solid cancer
- Registration Number
- CTRI/2018/12/016813
- Lead Sponsor
- Mitra RxDx India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient who has been recommended to undergo
CANscript testing, as a part of routine
clinical practice, by the treating physician.
Patient for whom the CANscript test report
(at least 1 reported M-score) is available
for review
Patient willing to provide informed consent
for prospective data collection
Exclusion Criteria
No specific exclusion criteria can be defined for the registry enrollment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method